Medical Patent News

RSS

Eli Lilly disagrees with U.S. Court of Appeals ruling on Gemzar method-of-use patent

Eli Lilly and Company today announced that the U.S. Court of Appeals for the Federal Circuit has upheld a prior ruling by the U.S. District Court for the Eastern District of Michigan that Gemzar's method-of-use patent is invalid.

29 Jul 2010

HemoBioTech receives patent for HemoTech treatment of acute blood loss

HemoBioTech announced today the issuance of a new patent US 7,759,306 B2, Methods of Treating Acute Blood Loss. HemoBioTech has an exclusive worldwide license from Texas Tech University to commercialize the technology. The new patent continues to May 16, 2026. The major advance in HemoTech is the presence of Adenosine which has anti-inflammatory activity.

29 Jul 2010

Redpoint Bio issued patent that covers high-throughput screening technology

Redpoint Bio Corporation, a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced the issuance of Patent No. 7,749,730 B2 by the U.S. Patent and Trademark Office entitled "High Throughput Screening Assay for the TRPm5 Ion Channel."

28 Jul 2010

Aphios awarded US patent for compositions, methods for treating diseases involving 5-α reductase enzyme

Aphios® Corporation today announced that it was awarded United States Patent No. 7,744,935 B2 for "Compositions and Methods for Inhibiting 5-α Reductase," granted June 29, 2010. This invention is related to compositions and methods for treating diseases involving the 5-alpha (α) reductase enzyme.

28 Jul 2010

USPTO grants two patents for Leto Medical's COS technology

Leto Medical, LLC, a privately held, early-stage medical device company, announced today that the United States Patent and Trademark Office has granted the company two patents (7,765,006 and 7,765,007) for its breakthrough Continent Ostomy System technology, a system of products that will restore continence control to individuals with colostomies.

28 Jul 2010

Integral Molecular receives patent for Lipoparticle membrane protein technology

Integral Molecular, Inc. today announced the issuance of a key patent covering its technology for deriving high concentrations of membrane proteins. The patent, issued by the U.S. Patent and Trademark Office, covers the core composition of Integral Molecular's Lipoparticle technology, a novel cell-free format for deriving highly-concentrated membrane proteins for antibody development, drug discovery, and biomedical research.

28 Jul 2010

Aperio receives patent for image viewing technology

Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry, announced today that the United States Patent and Trademark Office has issued the company patent No. 7,738,688 entitled, "System and Method for Viewing Virtual Slides."

28 Jul 2010

Progenra receives Official Notice of Allowance for screening platform

Progenra, Inc., announced today their receipt of an Official Notice of Allowance, dated June 15, 2010, of U.S. Patent Application No. 11/156,707, "Diagnostic and Screening Methods and Kits Associated with Proteolytic Activity." IP protection of this technology was also recently granted by the European Union. This technology will enable faster drug discovery by improving the ability to identify more selective drugs that modulate the handling of proteins associated with various disease states.

27 Jul 2010

Abviva to receive patent for its new Mammastatin technology

Abviva, Inc., a biomedical company engaged in the development and commercialization of breast cancer-related applications of Mammastatin, announced that the Canadian Patent Office issued notice that it will be issuing patent application Number 2.267.095 within 12 weeks

27 Jul 2010

Forest, Merz settle NAMENDA patent infringement litigation

Forest Laboratories, Inc. Forest Laboratories Holdings, Ltd., Merz Pharma GmbH & Co. KGaA, and Merz Pharmaceuticals GmbH announced today that they have entered into settlement agreements with all remaining defendants in patent infringement litigation related to Forest's NAMENDA® (memantine hydrochloride) immediate release tablets.

23 Jul 2010

Verify Brand granted US patent for 'Authentication and Tracking System'

Verify Brand announces it has received a United States patent (No. US 7,752,137 B2) for an "Authentication and Tracking System."

22 Jul 2010

Trinity receives USPTO Notice of Allowance for monoplanar pedicle screw method, system and kit

Trinity Orthopedics LLC, a medical device company that develops and markets products for minimally invasive spine surgery, announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a monoplanar pedicle screw method, system and kit. Trinity currently markets the posterior fixation system in the United States under the ReStor name.

22 Jul 2010

Applied Spine Technologies receives U.S. Patent for stabilization device with travel-limiting functionality

Applied Spine Technologies, a medical device company focused on motion preservation of the lumbar spine, received a Notice of Allowance on July 12, 2010 from the U.S. Patent and Trademark Office. To be clinically useful, a dynamic stabilization device needs to allow the spine to move, but not move excessively.

22 Jul 2010

Quick-Med Technologies receives USPTO Notice of Allowance for key NIMBUS antimicrobial technology patent

Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a key patent related to the Company's proprietary NIMBUS® antimicrobial technology.

21 Jul 2010

USPTO approves patent for Avisena's system for managing accounts receivables

Avisena, a provider of revenue cycle management software and services for physician practices, today announced that the United States Patent and Trademark Office has approved a patent for the company's "system for managing accounts receivables."

21 Jul 2010

SANUWAVE receives European patent, exclusive rights for Shock Wave Generating Device

An emerging medical technology company focused on regenerative medicine, reports that the Company was granted European patent EP 1,452,141 entitled "Shock Wave Generating Device," which provides the Company exclusive rights in human and animal treatment devices that include the novel use of piezoelectric fibers to produce acoustic energy in the shock wave spectrum.

21 Jul 2010

Patent application for inexpensive CyPath assay filed by Biomoda

Cancer diagnostics company Biomoda,filed a U.S. patent application on a quantitative method for scoring cells labeled with the CyPath® assay to determine whether cells are dysplastic or carcinomic by measuring the photon emission rate.

21 Jul 2010

CSIRO signs global licensing agreement for Reversible Addition-Fragmentation chain Transfer technology

CSIRO has signed a global licensing agreement for its patented RAFT technology. Reversible Addition-Fragmentation chain Transfer (or RAFT) technology is an elegant and powerful polymerisation process that has given rise to a new branch of polymer chemistry.

21 Jul 2010

DBS signs exclusive license agreement with JLB

Decas Botanical Synergies, LLC. today announced that it has signed an Exclusive License Agreement with a purchase option with JLB, Inc. developer and owner of broad-based patents covering cranberry and other vaccinium species.

20 Jul 2010

U.S. District Court upholds validity of Nycomed's Protonix patent

Nycomed announced today that Judge Jose L. Linares of the U.S. District Court for the District of New Jersey has confirmed the jury verdict in favor of Nycomed and Pfizer Inc. The decision upholds the jury verdict issued on April 23, 2010, confirming that the patent is valid and rejecting allegations by the defendants that the patent was invalid as obvious and invalid for double patenting. Against KUDCo, the US generic drug business of the Schwarz Pharma Group, which did not at-risk launch, final Judgment was entered as a result of Judge Jose L. Linares' rulings.

19 Jul 2010

Medical Patent News

Eli Lilly disagrees with U.S. Court of Appeals ruling on Gemzar method-of-use patent

HemoBioTech receives patent for HemoTech treatment of acute blood loss

Redpoint Bio issued patent that covers high-throughput screening technology

Aphios awarded US patent for compositions, methods for treating diseases involving 5-α reductase enzyme

USPTO grants two patents for Leto Medical's COS technology

Integral Molecular receives patent for Lipoparticle membrane protein technology

Aperio receives patent for image viewing technology

Progenra receives Official Notice of Allowance for screening platform

Abviva to receive patent for its new Mammastatin technology

Forest, Merz settle NAMENDA patent infringement litigation

Verify Brand granted US patent for 'Authentication and Tracking System'

Trinity receives USPTO Notice of Allowance for monoplanar pedicle screw method, system and kit

Applied Spine Technologies receives U.S. Patent for stabilization device with travel-limiting functionality

Quick-Med Technologies receives USPTO Notice of Allowance for key NIMBUS antimicrobial technology patent

USPTO approves patent for Avisena's system for managing accounts receivables

SANUWAVE receives European patent, exclusive rights for Shock Wave Generating Device

Patent application for inexpensive CyPath assay filed by Biomoda

CSIRO signs global licensing agreement for Reversible Addition-Fragmentation chain Transfer technology

DBS signs exclusive license agreement with JLB

U.S. District Court upholds validity of Nycomed's Protonix patent

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News